1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

        <em id="8sgz1"><label id="8sgz1"></label></em>
      2. <em id="8sgz1"><label id="8sgz1"></label></em>
        <em id="8sgz1"></em>
        <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

        <button id="8sgz1"></button>
        west china medical publishers
        Keyword
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Keyword "Graves 病" 3 results
        • Multi-disciplinary treatment of Graves’ disease with huge-size thyroid during peri-operative period

          Objective To explore the effect of multi-disciplinary treatment of the Graves’ disease (GD) with huge-size thyroid during perioperative period. Methods Retrospectively analyzed the clinical data of 8 GD patients with huge-size thyroid who got treatment in Pekin Union Medical College Hospital during Jan. 2006 to Dec. 2016. All patients underwent comprehensive preparation before operation and underwent total thyroidectomy. To explore the changes of thyroid function and culture after anti-thyroid drug (ATD)/iodine preparation/arterial embolization before operation, and to summarize situation of the bleeding loss intraoperation, neck-drainage, thyroid function, and relapses after operation. Results All cases got a satisfactory operation result after standard ATD, iodine preparation (Lugol’s solution 10–15 drops for 3–4 weeks, combined with ATDs for 2–3 weeks ), and main arterial embolization of thyroid in 24 h preoperation. They got shorter operative time (2.5–4.5 h), less bleeding intraoperation (4 cases≤100 mL), less neck-drainage, and almost normal retention time. No severe or permanent complications, for example thyroid storm, abnormal voice, and hypoparathyroid occurred. They were followed as outpatients for 18–133 months, and were found a perfect long-term effect without complication and relapse. Conclusions Perioperative period management is very important to those GD patients with huge-sized thyroid, and multi-disciplinary treatment can decrease theintraoperation bleeding, as well as occurrence of thyroid storm effectively. In addition, operated subtly during surgery can protect the recurrent laryngeal nerve and parathyroid effectively.

          Release date:2018-10-11 02:52 Export PDF Favorites Scan
        • Graves 病并雙手指黏液性水腫一例

          Release date:2018-05-24 02:12 Export PDF Favorites Scan
        • Change of Serum TRAb Level in Patients with Graves’ Ophthalmopathy before and after Treated with 131I

          目的 探討碘131(131I)治療后Graves眼病(GO)預后與血清促甲狀腺激素受體抗體(TRAb)水平變化之間的關系。 方法 選擇2011年5月-12月初發Graves病患者238例,分為GO組124 例和非GO組114 例,分別檢測131I治療前及131I治療后2、3、6個月甲狀腺功能和TRAb,GO患者131I治療前和治療后6 個月進行臨床活動度評分(CAS)。 結果 131I治療前各組TRAb水平差異無統計學意義(P>0.05),TRAb水平與GO CAS評分之間無相關;131I治療后6個月所有患者TRAb水平顯著增加;非GO組有5例新發GO,新發GO組與其他患者的TRAb水平分別為(58.7 ± 77.9)、(61.9 ± 81.1)U/L,差異無統計學意義(P>0.05);GO組又分為GO無變化29例,GO加重17例,GO緩解78例,三組患者TRAb水平分別為(53.5 ± 77.6)、(66.2 ± 89.9)、(66.8 ± 42.2)U/L,差異無統計學意義(P>0.05)。 結論 131I治療后患者TRAb水平顯著增加,但TRAb水平的變化和GO預后無關,TRAb與GO的關系還需要進一步研究。

          Release date:2016-08-26 02:09 Export PDF Favorites Scan
        1 pages Previous 1 Next

        Format

        Content

          1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

            <em id="8sgz1"><label id="8sgz1"></label></em>
          2. <em id="8sgz1"><label id="8sgz1"></label></em>
            <em id="8sgz1"></em>
            <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

            <button id="8sgz1"></button>
            欧美人与性动交α欧美精品